Meridian Bioscience (VIVO) Posts Q4 adj.-EPS of $0.15, Shy of Views; Declares $0.19 Quarterly Dividend; 3.2% Yield; Reaffirms FY11 Outlook

November 11, 2010 8:01 AM

Meridian Bioscience (Nasdaq: VIVO) reports Q4 non-GAAP EPS of $0.15, versus the consensus of $0.18. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found